What is Medline's target valuation for its upcoming IPO?

Medline is targeting an initial public offering valuation of up to $55.3 billion.

When is Medline's IPO expected to be the largest of the year?

Medline's IPO is expected to be the largest of 2025, with significant market anticipation for its debut.

Who are the key investors interested in Medline's IPO?

Cornerstone investors including Baillie Gifford and Capital Research Global Investors have indicated interest, alongside members of the Mills family.

Home / Business and Economy / Medline Eyes $55B Valuation in 2025's Biggest IPO

Medline Eyes $55B Valuation in 2025's Biggest IPO

9 Dec

•

Summary

Medline targets up to $55.3 billion valuation for its U.S. IPO.
The offering aims to raise as much as $5.37 billion.
This IPO is poised to be the largest of 2025.

Medical supplies leader Medline is preparing for what could be 2025's largest initial public offering, aiming for a valuation of up to $55.3 billion. The company intends to offer 179 million shares within a price range of $26 to $30 each, potentially raising over $5.37 billion.

This anticipated blockbuster IPO is set to be a crucial gauge of investor confidence as the market heads into the new year. Despite earlier market headwinds, U.S. IPO activity has seen its highest levels since the 2021 boom, with Medline's offering testing appetite beyond technology sectors.

Founded in 1966 and tracing its roots to a garment manufacturer from 1910, Medline has a long history. Acquired by private equity firms in 2021 for $34 billion, the company reported strong net income and sales growth in the nine months ending September 27, 2025.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.